Latest / tv.qiagenbioinformatics.com
From promising biology to actionable opportunities: Rethinking target...
Which targets are you missing when you analyze genetics, 'omics or single-cell data alone?
Focusing on amyotrophic lateral sclerosis (ALS), a complex neuroinflammatory disease with limited therapeutic options and heterogeneous disease biology, we explore how pharma R&D teams can identify high-confidence, developable targets. Instead of focusing on known ALS genes, uncover new targets and disease mechanisms by combining knowledge graphs, multiomics and single-cell data.
See how integrated data analysis can reveal novel, evidence-backed targets – and determine which discoveries are worth…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.